ロード中...
Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens
BACKGROUND: Etravirine (ETR), a non-nucleoside reverse transcriptase inhibitor (NNRTI) available in France since 2006, is indicated for antiretroviral-experienced HIV-infected adults, in combination with a ritonavir-boosted protease inhibitor (PI). To assess its clinical impact in routine care, we c...
保存先:
| 出版年: | BMC Infect Dis |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6042265/ https://ncbi.nlm.nih.gov/pubmed/29996784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-018-3231-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|